CUL-7 Antibodies

Santa Cruz Biotechnology delivers a wide array of CUL-7 monoclonal antibodies for research focused on understanding CUL-7 protein functions. The monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CUL-7, a member of the cullin family of proteins, plays a critical role in regulating cell cycle progression and maintaining genomic stability. It is involved in the ubiquitin-proteasome pathway, which is essential for the degradation of specific proteins that control cell division and apoptosis. Dysregulation of CUL-7 has been implicated in various cancers and developmental disorders, highlighting its importance in cellular homeostasis and disease mechanisms. Researchers can investigate CUL-7's role in cell cycle regulation using multiple experimental approaches. Understanding CUL-7's function in protein degradation pathways provides insights into potential therapeutic targets. The relationship between CUL-7 and cancer development continues to be an active area of investigation. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific understanding of CUL-7's role in human health and disease.